Please use this identifier to cite or link to this item:
Title: Evaluation and refinement of the PRESTARt tool for identifying 12-14 year olds at high lifetime risk of developing type 2 diabetes compared to a clinicians assessment of risk: a cross-sectional study
Authors: Gray, L
Brady, E
Albaina, O
Edwardson, C
Harrington, D
Khunti, K
Miksza, J
Raposo, J
Smith, E
Vazeou, A
Vergara, I
Weihrauch-Blüher, S
Davies, M
First Published: 2019
Publisher: BMC (part of Springer Nature)
Citation: BMC Endocrine Disorders, 2019, In Press
Abstract: Background: Traditionally Type 2 Diabetes Mellitus (T2DM) was associated with older age, but is now being increasingly diagnosed in younger populations due to the increasing prevalence of obesity and inactivity. We aimed to evaluate whether a tool developed for community use to identify adolescents at high lifetime risk of developing T2DM agreed with a risk assessment conducted by a clinician using data collected from five European countries. We also assessed whether the tool could be simplified. Methods: To evaluate the tool we collected data from 636 adolescents aged 12-14 years from five European countries. Each participant’s data were then assessed by two clinicians independently, who judged each participant to be at either low or high risk of developing T2DM in their lifetime. This was used as the gold standard to which the tool was evaluated and refined. Results: The refined tool categorised adolescents at high risk if they were overweight/obese and had at least one other risk factor (High waist circumference, family history of diabetes, parental obesity, not breast fed, high sugar intake, high screen time, low physical activity and low fruit and vegetable intake). Of those found to be at high risk by the clinicians, 93% were also deemed high risk by the tool. The specificity shows that 67% of those deemed at low risk by the clinicians were also found to be a low risk by the tool. Conclusions: We have evaluated a tool for identifying adolescents with risk factors associated with the development of T2DM in the future. Future work to externally validate the tool using prospective data including T2DM incidence is required.
eISSN: 1472-6823
Links: TBA
Embargo on file until: 1-Jan-10000
Version: Post-print
Status: Peer-reviewed
Type: Journal Article
Rights: Copyright © 2019, BMC (part of Springer Nature). Deposited with reference to the publisher’s open access archiving policy. (
Description: The file associated with this record is under embargo until publication, in accordance with the publisher's self-archiving policy. The full text may be available through the publisher links provided above.
Appears in Collections:Published Articles, Dept. of Health Sciences

Files in This Item:
File Description SizeFormat 
Additional file 1.pdfPost-review (final submitted author manuscript)1.1 MBAdobe PDFView/Open
Additional file 2.pdfPost-review (final submitted author manuscript)400.59 kBAdobe PDFView/Open
Additional file 3.docxPost-review (final submitted author manuscript)29.57 kBUnknownView/Open
Additional file 4.docxPost-review (final submitted author manuscript)13.23 kBUnknownView/Open
Phase+1+revised+paper+ed+2nd+revision.pdfPost-review (final submitted author manuscript)526.82 kBAdobe PDFView/Open

Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.